14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RHY.AX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Rhythm Biosciences Limited
(Updated on Jun 14, 2024)

Sell candidate since Jun 06, 2024 Loss -5.71% PDF

The Rhythm Biosciences Limited stock price fell by -1.49% on the last day (Friday, 14th Jun 2024) from $0.0670 to $0.0660. During the last trading day the stock fluctuated 3.13% from a day low at $0.0640 to a day high of $0.0660. The price has been going up and down for this period, and there has been a -2.94% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -66 thousand shares and in total, 45 thousand shares were bought and sold for approximately $2.98 thousand.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0649 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -32.49% during the next 3 months and, with a 90% probability hold a price between $0.0438 and $0.0483 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RHY.AX Signals & Forecast

There are mixed signals in the stock today. The Rhythm Biosciences Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0687 and $0.0743. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, June 12, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Rhythm Biosciences Limited stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0020 between high and low, or 3.13%. For the last week the stock has had daily average volatility of 4.02%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RHY.AX) For The Upcoming Trading Day Of Monday 17th

For the upcoming trading day on Monday, 17th we expect Rhythm Biosciences Limited to open at $0.0653, and during the day (based on 14 day Average True Range), to move between $0.0631 and $0.0689, which gives a possible trading interval of +/-$0.0029 (+/-4.43%) up or down from last closing price. If Rhythm Biosciences Limited takes out the full calculated possible swing range there will be an estimated 8.87% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0680, some $0.0020 (3.03%) from the current price of $0.0660, our system finds the risk reward not very attractive.

Is Rhythm Biosciences Limited stock A Buy?

Rhythm Biosciences Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.623 Sell Candidate Unchanged

Predicted Opening Price for Rhythm Biosciences Limited of Monday, June 17, 2024

Fair opening price June 17, 2024 Current price
$0.0653 ( 1.01%) $0.0660

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RHY.AX

Fibonacci Support & Resistance Levels

Level Price
R3 0.0673 2.02%
R2 0.0666 0.86%
R1 0.0661 0.147%
Price 0.0660
S1 0.0646 -2.17%
S2 0.0641 -2.88%
S3 0.0633 -4.04%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0810 22.73%
R2 0.0700 6.06%
R1 0.0680 3.03%
Price 0.0660
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Rhythm Biosciences Limited Stock and on which exchange is it traded?
The symbol for Rhythm Biosciences Limited is RHY.AX and it is traded on the ASX (Australian Securities Exchange).

Should I buy or sell Rhythm Biosciences Limited Stock?
Rhythm Biosciences Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Rhythm Biosciences Limited Stock?
Rhythm Biosciences Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rhythm Biosciences Limited Stock.

What's the current price of Rhythm Biosciences Limited Stock?
As of the end of day on the Jun 14, 2024, the price of an Rhythm Biosciences Limited (RHY.AX) share was $0.0660.

What is the 52-week high and low for Rhythm Biosciences Limited Stock?
The 52-week high for Rhythm Biosciences Limited Stock is $0.550 and the 52-week low is $0.0630.

What is the market capitalization of Rhythm Biosciences Limited Stock?
As of the Jun 14, 2024, the market capitalization of Rhythm Biosciences Limited is 16.671M.

When is the next earnings date for Rhythm Biosciences Limited?
The upcoming earnings date for Rhythm Biosciences Limited is Aug 29, 2024.
Click to get the best stock tips daily for free!

About Rhythm Biosciences Limited

Rhythm Biosciences Limited Rhythm Biosciences Limited, a transformative diagnostics company, engages in developing and commercializing of medical diagnostics technology in Australia and internationally. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is based in Parkville, Australia.... RHY.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT